UnitedHealth Group Incorporated $UNH Shares Purchased by S&CO Inc.

S&CO Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 26.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,768 shares of the healthcare conglomerate’s stock after buying an additional 9,597 shares during the period. UnitedHealth Group accounts for about 0.9% of S&CO Inc.’s portfolio, making the stock its 29th largest holding. S&CO Inc.’s holdings in UnitedHealth Group were worth $14,278,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in UNH. HHM Wealth Advisors LLC boosted its stake in UnitedHealth Group by 0.9% during the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after purchasing an additional 26 shares during the last quarter. Brogan Financial Inc. grew its stake in UnitedHealth Group by 3.4% during the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after acquiring an additional 27 shares in the last quarter. West Wealth Group LLC lifted its stake in UnitedHealth Group by 3.2% in the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock worth $462,000 after purchasing an additional 27 shares in the last quarter. Hemington Wealth Management grew its position in shares of UnitedHealth Group by 2.5% in the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after purchasing an additional 28 shares in the last quarter. Finally, Tlwm lifted its position in UnitedHealth Group by 1.0% during the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after buying an additional 28 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.8%

UNH opened at $324.29 on Monday. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a market cap of $293.75 billion, a P/E ratio of 16.93, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The business has a fifty day simple moving average of $345.84 and a 200-day simple moving average of $321.90.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.15 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on UNH. Royal Bank Of Canada lifted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Bank of America boosted their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Mizuho increased their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Finally, Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.